| Line item in (gbp) | 01.04.2020 | 01.04.2021 | 01.04.2022 |
|---|---|---|---|
| Assets | N/A | 191,758,000.00 | 301,283,000.00 |
| Property Plant And Equipment | N/A | 6,000.00 | 9,000.00 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | 164,127,000.00 | 268,807,000.00 |
| Other Current Receivables | N/A | 47,000.00 | 391,000.00 |
| Cash and cash equivalents | 15,111,000.00 | 27,433,000.00 | 31,326,000.00 |
| Equity | 135,793,000.00 | 183,162,000.00 | 295,204,000.00 |
| Issued Capital | N/A | 1,405,000.00 | 1,810,000.00 |
| Retained Earnings | N/A | -7,371,000.00 | -11,169,000.00 |
| Share Premium | N/A | 52,151,000.00 | 105,383,000.00 |
| Capital Reserve | N/A | 44,876,000.00 | 107,989,000.00 |
| Current Provisions | N/A | 6,508,000.00 | 0.00 |
| Other Current Payables | N/A | 1,940,000.00 | 5,296,000.00 |
| Line item in (gbp) | 01.04.2020/ 01.04.2021 |
01.04.2021/ 01.04.2022 |
|---|---|---|
| Revenue From Interest | 7,000.00 | 3,000.00 |
| Profit Loss Before Tax | 19,676,000.00 | 59,315,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 |
| Profit (loss) | 19,676,000.00 | 59,315,000.00 |
| Line item in (gbp) | 01.04.2020 | 01.04.2021 | 01.04.2022 |
|---|---|---|---|
| Profit (loss) | N/A | 19,676,000.00 | 59,315,000.00 |
| Interest Received Classified As Operating Activities | N/A | 68,000.00 | 1,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -15,371,000.00 | -48,834,000.00 |
| Proceeds From Issuing Shares | N/A | 28,046,000.00 | 55,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 51,000.00 | 910,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 27,693,000.00 | 52,727,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 12,322,000.00 | 3,893,000.00 |
| Cash and cash equivalents | 15,111,000.00 | 27,433,000.00 | 31,326,000.00 |
Please note that some sums might not add up.
GB00BG12XV81
213800OTQ44T555I8S71
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.
